Semaglutide Injection 1mg/1.5ml PFS Manufacturer
Our Certifications
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
WHO-GMPCertified
GMPCertified
ISO 9001:2015Certified
GLPCertified
Global Presence
Our products are trusted and supplied across 40+ countries worldwide.
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
Product Overview
Sanjar Pharma manufactures Semaglutide Injection 1mg/1.5ml in a prefilled syringe format at its WHO-GMP compliant sterile injectable manufacturing facility. The product is manufactured using validated pharmaceutical processes, advanced quality systems, and controlled sterile production environments designed to support product consistency and supply reliability.
Semaglutide belongs to the GLP-1 Receptor Agonist class of medicines and is part of a growing category of specialty injectable products used in metabolic healthcare programs. The prefilled syringe presentation supports dosing accuracy, administration convenience, and efficient product handling within healthcare settings.
Supported by modern sterile manufacturing infrastructure, analytical laboratories, microbiology facilities, and export-focused pharmaceutical operations, Sanjar Pharma supplies Semaglutide Injection to pharmaceutical companies, healthcare organizations, distributors, and international pharmaceutical markets.
Technical Specifications
| Generic Name | Semaglutide |
|---|---|
| Strength | 1mg/1.5ml |
| Brand Name | SP-TIDE |
| Therapeutic Category | Antidiabetic Agent |
| Dosage Form | Prefilled Syringe (PFS) |
| Route of Administration | Subcutaneous Injection |
| Product Type | Sterile Injectable |
| Manufacturing Standard | WHO-GMP |
| Supply Type | Commercial Supply |
| Contract Manufacturing | Available |
| Third Party Manufacturing | Available |
| Regulatory Documentation | Available Upon Request |
| Storage Condition | As Per Approved Product Specifications |
| Export Supply | Available |
Specialty Injectable Manufacturing Excellence
Sanjar Pharma operates a WHO-GMP compliant sterile injectable manufacturing facility equipped with advanced production systems, quality control laboratories, microbiology testing infrastructure, and validated environmental controls designed to support specialty pharmaceutical products.
Why Choose Sanjar Pharma for Semaglutide Injection Manufacturing
-
Expertise in Sterile Injectable Manufacturing
-
WHO-GMP Certified Pharmaceutical Facility
-
Advanced Quality Control Infrastructure
-
Comprehensive Microbiology Testing Programs
-
Specialty Pharmaceutical Manufacturing Capabilities
-
Export-Oriented Manufacturing Operations
-
Contract Manufacturing Support
-
Third Party Manufacturing Solutions
Industries We Serve
Enquire About This Product
Submit your requirement parameters below for rapid commercial export handling.
